gimli

JENBURPH stock AI analysis

JENBURPH Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

JENBURKT PHARMACEUTICAL L is a small-cap stock in Healthcare. This Gimli page shows the latest available JENBURPH price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive JENBURPH stock page

Price

₹947.10

1W return

+3.48%

1M return

-7.48%

3M return

n/a

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+18.84%

ROCE

+25.04%

RSI

44.95

Turnover

₹0.09 cr

Why it can matter in screens

Momentum: JENBURPH is below 50DMA, below 200DMA; RSI is 44.95.
Returns: 1D -0.74%, 1W +3.48%, 1M -7.48%, 3M n/a, 1Y n/a.
Trend levels: 52W high ₹1,073.90, 52W low ₹864.00, off high -11.81%.
Liquidity: latest turnover is ₹0.09 cr; volume vs 20D is +0.31%.
Valuation/profitability: PE n/a, PB n/a, ROE +18.84%, ROCE +25.04%.
Growth: 3Y sales CAGR +7.42%, 3Y profit CAGR +12.17%.

Quick Answers

What is the latest JENBURPH stock price?

The latest stored price for JENBURPH is Rs 947.10 as of 2026-10-09.

Is JENBURPH above its 50DMA and 200DMA?

JENBURPH is below 50DMA, below 200DMA. The latest 50DMA is n/a and the latest 200DMA is n/a.

What are JENBURPH PE, ROE and ROCE?

JENBURPH has PE n/a, ROE +18.84%, and ROCE +25.04% in Gimli's latest available snapshot.

How has JENBURPH performed recently?

JENBURPH has returned -7.48% over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	44.63 cr	14.65 cr	10.85 cr	n/a
2025-12-31	43.02 cr	9.24 cr	5.93 cr	n/a
2025-06-30	35.53 cr	11.01 cr	7.79 cr	n/a
2025-03-31	41.05 cr	12.74 cr	8.54 cr	n/a
2024-12-31	36.89 cr	10.40 cr	6.51 cr	n/a

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	168.74 cr	50.09 cr	34.74 cr	78.71
2025-03-31	151.69 cr	47.11 cr	32.06 cr	72.65
2024-03-31	141.63 cr	37.75 cr	25.98 cr	58.86
2023-03-31	136.14 cr	35.42 cr	24.61 cr	53.90
2022-03-31	n/a	n/a	n/a	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	226.01 cr	5.58 cr	2.49 cr	197.04 cr
2025-03-31	196.19 cr	7.36 cr	3.89 cr	171.78 cr
2024-03-31	165.10 cr	4.13 cr	0.00 cr	144.94 cr
2023-03-31	141.81 cr	3.66 cr	2.93 cr	122.39 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	26.52 cr	12.80 cr	n/a
2025-03-31	27.91 cr	8.19 cr	n/a
2024-03-31	8.12 cr	5.57 cr	n/a
2023-03-31	17.05 cr	14.95 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	422,282.96 cr	34.857273	+15.50%	+6.12%
DIVISLAB	DIVI S LABORATORIES LTD	247,947.67 cr	85.088426	+18.37%	+52.32%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,610.64 cr	72.265309	+17.33%	+31.16%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	115,423.17 cr	58.937484	+21.03%	+4.32%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	112,446.65 cr	25.058308	+16.04%	+12.37%
LAURUSLABS	LAURUS LABS LIMITED	109,947.20 cr	100.670416	+21.77%	+135.42%
CIPLA	CIPLA LTD	105,094.85 cr	31.162389	+10.25%	-14.02%
DRREDDY	DR. REDDY S LABORATORIES	99,661.60 cr	30.096514	+9.23%	-3.94%

Try these prompts

Analyze JENBURKT PHARMACEUTICAL L with valuation, momentum and industry peers
Compare JENBURPH with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-10-09. Not investment advice.